CAROL ANTEQUERA: Open Payments
NPI 1063710549 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$16,998 in 52 payments from 15 companies in 2025. Trend: 2023 $22,247 · 2024 $35,916 · 2025 $16,998
Speaker / faculty: $8,215Consulting: $6,215Food & beverage: $1,491Travel & lodging: $1,077
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 9 | $4,266 |
| ABBVIE INC. | 6 | $2,621 |
| Regeneron Healthcare Solutions, Inc. | 4 | $2,397 |
| EVOKE PHARMA, INC. | 5 | $2,248 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 10 | $1,948 |
| Regeneron Pharmaceuticals, Inc. | 3 | $1,221 |
| Novo Nordisk Inc | 2 | $1,182 |
| Ardelyx, Inc. | 4 | $778 |
| IRONWOOD PHARMACEUTICALS, INC | 1 | $83 |
| Aimmune Therapeutics, Inc. | 3 | $80 |
Products named: DUPIXENT, GIMOTI, TRULANCE, IBSRELA, XIFAXAN, Linzess, ZENPEP, Cologuard Collection Kit.
Industry payments across FL — which companies pay providers there.
